Detalhe da pesquisa
1.
Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine: Updated Interim Recommendations from the Advisory Committee on Immunization Practices - United States, December 2021.
MMWR Morb Mortal Wkly Rep
; 71(3): 90-95, 2022 Jan 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-35051137
2.
The Advisory Committee on Immunization Practices' Recommendation for Use of Moderna COVID-19 Vaccine in Adults Aged ≥18 Years and Considerations for Extended Intervals for Administration of Primary Series Doses of mRNA COVID-19 Vaccines - United States, February 2022.
MMWR Morb Mortal Wkly Rep
; 71(11): 416-421, 2022 Mar 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-35298454
3.
Respiratory Illness Caused by Corynebacterium diphtheriae and C. ulcerans, and Use of Diphtheria Antitoxin in the United States, 1996-2018.
Clin Infect Dis
; 73(9): e2799-e2806, 2021 11 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32818967
4.
The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Adolescents Aged 12-15 Years - United States, May 2021.
MMWR Morb Mortal Wkly Rep
; 70(20): 749-752, 2021 May 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-34014913
5.
Updated Recommendations from the Advisory Committee on Immunization Practices for Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine After Reports of Thrombosis with Thrombocytopenia Syndrome Among Vaccine Recipients - United States, April 2021.
MMWR Morb Mortal Wkly Rep
; 70(17): 651-656, 2021 Apr 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-33914723
6.
The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Children Aged 5-11 Years - United States, November 2021.
MMWR Morb Mortal Wkly Rep
; 70(45): 1579-1583, 2021 Nov 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34758012
7.
Use of Pfizer-BioNTech COVID-19 Vaccine in Persons Aged ≥16 Years: Recommendations of the Advisory Committee on Immunization Practices - United States, September 2021.
MMWR Morb Mortal Wkly Rep
; 70(38): 1344-1348, 2021 Sep 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34555007
8.
Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices - United States, June 2021.
MMWR Morb Mortal Wkly Rep
; 70(27): 977-982, 2021 Jul 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34237049
9.
The Advisory Committee on Immunization Practices' Interim Recommendations for Additional Primary and Booster Doses of COVID-19 Vaccines - United States, 2021.
MMWR Morb Mortal Wkly Rep
; 70(44): 1545-1552, 2021 Nov 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34735422
10.
Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices - United States, July 2021.
MMWR Morb Mortal Wkly Rep
; 70(32): 1094-1099, 2021 Aug 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-34383735
11.
Modeling Poliovirus Transmission in Pakistan and Afghanistan to Inform Vaccination Strategies in Undervaccinated Subpopulations.
Risk Anal
; 38(8): 1701-1717, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29314143
12.
The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Janssen COVID-19 Vaccine - United States, February 2021.
MMWR Morb Mortal Wkly Rep
; 70(9): 329-332, 2021 03 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33661860
13.
Country Data for Action: The MenAfriNet Experience in Strengthening Meningitis Surveillance in Africa.
J Infect Dis
; 220(220 Suppl 4): S137-S139, 2019 10 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-31671440
14.
Polio eradication initiative in Afghanistan, 1997-2013.
J Infect Dis
; 210 Suppl 1: S162-72, 2014 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25316832
15.
Population-based surveillance for bacterial meningitis in China, September 2006-December 2009.
Emerg Infect Dis
; 20(1): 61-9, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24377388
16.
Supporting National Immunization Technical Advisory Groups (NITAGs) in development of evidence-based vaccine recommendations and NITAG assessments - New tools and approaches.
Vaccine
; 2024 Jan 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38267328
17.
Region-wide assessment of National Immunization Technical Advisory Groups (NITAGs) using the NITAG Maturity Assessment Tool (NMAT) - Experience from the Eastern Mediterranean Region of the World Health Organization, 2023.
Vaccine
; 42(9): 2239-2245, 2024 Apr 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38413276
18.
The Brighton collaboration standardized module for vaccine benefit-risk assessment.
Vaccine
; 42(4): 972-986, 2024 Feb 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38135642
19.
A summary of the Advisory Committee for Immunization Practices (ACIP) use of a benefit-risk assessment framework during the first year of COVID-19 vaccine administration in the United States.
Vaccine
; 41(44): 6456-6467, 2023 Oct 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37527956
20.
Epidemic Intelligence Service investigations of respiratory illness, 1946-2005.
Am J Epidemiol
; 174(11 Suppl): S36-46, 2011 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22135392